Amelia S. Wallace
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amelia S. Wallace has a total of 293 co-authors. Here are the top co-authors by number of shared publications:
Jeffrey P. Jacobs
Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
16 shared publicationsMarshall L. Jacobs
Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
14 shared publications- Elizabeth Selvin
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health 3 , Baltimore, MD
11 shared publications Kevin D. Hill
Duke Clinical Research Institute, Duke University, Durham, North Carolina
11 shared publicationsSara K. Pasquali
University of Michigan, Ann Arbor, MI, USA
10 shared publications- Mary R. Rooney
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health 1 , Baltimore, MD
9 shared publications
Latest Publications
- 7 July 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (1) , 58-62
Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023
- 7 July 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (1) , 58-62
Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023
- 16 June 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (2) , H490-H497
Metabolic and Redox Pathway Dysregulation in HIV-Associated Coronary Endothelial Dysfunction
People with HIV (PWH) remain at increased risk for cardiovascular disease despite sustained viral suppression on antiretroviral therapy, but the biological mechanisms underlying this risk are incompletely understood. We hypothesized that coronary endothelial dysfunction in virally suppressed PWH is associated with specific circulating proteomic signatures reflecting metabolic and redox pathway dysregulation. We conducted a prospective observational study integrating in vivo stress cardiovascular magnetic resonance imaging with high-throughput serum proteomics to investigate mechanisms of coronary endothelial dysfunction in treated HIV. Forty-five virally suppressed PWH and twenty-nine age- and sex-matched healthy controls underwent coronary magnetic resonance imaging during isometric handgrip exercise to quantify coronary endothelial function, defined as the percent change in coronary cross-sectional area from rest to stress, with an increase <2% indicating endothelial dysfunction. Parallel serum proteomic profiling was performed using the SomaScan 7K platform, and differential protein expression was analyzed using linear modeling. Coronary endothelial dysfunction was significantly more prevalent among PWH than controls (67% vs 10%, p<0.001). Pathway enrichment analysis of differentially expressed proteins between participants with and without endothelial dysfunction identified significant dysregulation of glutathione-dependent detoxification, oxidative metabolism, and fatty acid β-oxidation pathways (adjusted p<0.05). However, despite the higher prevalence of coronary endothelial dysfunction among PWH compared with controls without HIV, we did not identify a distinct baseline clinical or proteomic profile that fully explained this difference. These findings demonstrate that coronary endothelial dysfunction in virally suppressed PWH is associated with metabolic and redox imbalance, identifying glutathione and fatty acid oxidation pathways as potential therapeutic targets to mitigate residual cardiovascular risk in this population.
- 16 June 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (2) , H490-H497
Metabolic and Redox Pathway Dysregulation in HIV-Associated Coronary Endothelial Dysfunction
People with HIV (PWH) remain at increased risk for cardiovascular disease despite sustained viral suppression on antiretroviral therapy, but the biological mechanisms underlying this risk are incompletely understood. We hypothesized that coronary endothelial dysfunction in virally suppressed PWH is associated with specific circulating proteomic signatures reflecting metabolic and redox pathway dysregulation. We conducted a prospective observational study integrating in vivo stress cardiovascular magnetic resonance imaging with high-throughput serum proteomics to investigate mechanisms of coronary endothelial dysfunction in treated HIV. Forty-five virally suppressed PWH and twenty-nine age- and sex-matched healthy controls underwent coronary magnetic resonance imaging during isometric handgrip exercise to quantify coronary endothelial function, defined as the percent change in coronary cross-sectional area from rest to stress, with an increase <2% indicating endothelial dysfunction. Parallel serum proteomic profiling was performed using the SomaScan 7K platform, and differential protein expression was analyzed using linear modeling. Coronary endothelial dysfunction was significantly more prevalent among PWH than controls (67% vs 10%, p<0.001). Pathway enrichment analysis of differentially expressed proteins between participants with and without endothelial dysfunction identified significant dysregulation of glutathione-dependent detoxification, oxidative metabolism, and fatty acid β-oxidation pathways (adjusted p<0.05). However, despite the higher prevalence of coronary endothelial dysfunction among PWH compared with controls without HIV, we did not identify a distinct baseline clinical or proteomic profile that fully explained this difference. These findings demonstrate that coronary endothelial dysfunction in virally suppressed PWH is associated with metabolic and redox imbalance, identifying glutathione and fatty acid oxidation pathways as potential therapeutic targets to mitigate residual cardiovascular risk in this population.
- 17 February 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (7) , 480-492
Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women
BACKGROUND: Cardiovascular disease (CVD) prevalence is rising among younger women in the United States. Hypertensive disorders of pregnancy (HDP) are early indicators of cardiovascular risk, yet it remains unclear whether HDP independently increase CVD risk or reflect poor prepregnancy health. We aimed to quantify the association between HDP and incident CVD in a diverse, real-world population, with replication of findings across health systems. METHODS: We used data from the All of Us research program, encompassing >50 health systems across the United States, to identify women with longitudinal pregnancy and postpartum data (n=17 357; between 2007 and 2022). Multivariable Cox regression estimated adjusted hazard ratios (aHRs) of HDP with CVD (ischemic heart disease, heart failure, or stroke), overall and stratified by prepregnancy cardiometabolic risk factors (hypertension, obesity, diabetes, hyperlipidemia, or chronic kidney disease). Analyses were replicated in an independent health system (n=56 549; between 2016 and 2025) using the Observational Medical Outcomes Partnership Common Data Model. RESULTS: Participants had a median [interquartile range] age of 30 [25, 35] years; 2719 (16%) identified as Black or African American, and 7267 (42%) identified as Hispanic or Latino. Among those who reported socioeconomic data, 4306 (35%) reported an income <$25 000, and 6429 (37%) a high school education at most. HDP occurred in 2098 (12%) of pregnancies. Over a median of 4.6 years of follow-up, 701 women developed CVD. Overall, HDP were associated with elevated CVD risk (aHR, 1.82 [95% CI, 1.49–2.22]). Regardless of prepregnancy cardiometabolic risk factors, HDP were independently associated with CVD risk (aHR, 2.06 [95% CI, 1.55–2.74] among women without risk factors, and aHR, 1.33 [95% CI, 1.00–1.77] among women with risk factors). Main findings showed similar effect estimates for the risk of HDP with composite CVD (aHR, 2.62 [95% CI, 2.17–3.16]) in the external replication cohort. CONCLUSIONS: In a diverse, national sample of young US women, HDP were a significant marker of premature CVD risk, even in the absence of prepregnancy cardiometabolic risk factors. Integrating pregnancy complications into CVD risk stratification and promoting cardiometabolic health before, during, and after pregnancy may reduce the growing burden of early-onset CVD among women.
- 17 February 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (7) , 480-492
Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women
BACKGROUND: Cardiovascular disease (CVD) prevalence is rising among younger women in the United States. Hypertensive disorders of pregnancy (HDP) are early indicators of cardiovascular risk, yet it remains unclear whether HDP independently increase CVD risk or reflect poor prepregnancy health. We aimed to quantify the association between HDP and incident CVD in a diverse, real-world population, with replication of findings across health systems. METHODS: We used data from the All of Us research program, encompassing >50 health systems across the United States, to identify women with longitudinal pregnancy and postpartum data (n=17 357; between 2007 and 2022). Multivariable Cox regression estimated adjusted hazard ratios (aHRs) of HDP with CVD (ischemic heart disease, heart failure, or stroke), overall and stratified by prepregnancy cardiometabolic risk factors (hypertension, obesity, diabetes, hyperlipidemia, or chronic kidney disease). Analyses were replicated in an independent health system (n=56 549; between 2016 and 2025) using the Observational Medical Outcomes Partnership Common Data Model. RESULTS: Participants had a median [interquartile range] age of 30 [25, 35] years; 2719 (16%) identified as Black or African American, and 7267 (42%) identified as Hispanic or Latino. Among those who reported socioeconomic data, 4306 (35%) reported an income <$25 000, and 6429 (37%) a high school education at most. HDP occurred in 2098 (12%) of pregnancies. Over a median of 4.6 years of follow-up, 701 women developed CVD. Overall, HDP were associated with elevated CVD risk (aHR, 1.82 [95% CI, 1.49–2.22]). Regardless of prepregnancy cardiometabolic risk factors, HDP were independently associated with CVD risk (aHR, 2.06 [95% CI, 1.55–2.74] among women without risk factors, and aHR, 1.33 [95% CI, 1.00–1.77] among women with risk factors). Main findings showed similar effect estimates for the risk of HDP with composite CVD (aHR, 2.62 [95% CI, 2.17–3.16]) in the external replication cohort. CONCLUSIONS: In a diverse, national sample of young US women, HDP were a significant marker of premature CVD risk, even in the absence of prepregnancy cardiometabolic risk factors. Integrating pregnancy complications into CVD risk stratification and promoting cardiometabolic health before, during, and after pregnancy may reduce the growing burden of early-onset CVD among women.
- 9 January 2026
- Published by American Diabetes Association in Diabetes Care
- Vol. 49 (3) , e40-e42
Defining Clinically Interpretable Glycemic Profiles Using Continuous Glucose Monitoring in Type 2 Diabetes
- 9 January 2026
- Published by American Diabetes Association in Diabetes Care
- Vol. 49 (3) , e40-e42
Defining Clinically Interpretable Glycemic Profiles Using Continuous Glucose Monitoring in Type 2 Diabetes
- Open Access
Metabolic and Redox Pathway Dysregulation in HIV-Associated Coronary Endothelial Dysfunction
Background: People with HIV (PWH), even with sustained viral suppression on antiretroviral therapy (ART), remain at increased risk for cardiovascular disease. Coronary endothelial dysfunction, a sensitive marker of early vascular injury and a potential target for intervention is common in this population, but its biological basis remains unknown. Methods: We performed a cross-sectional study combining in vivo coronary MRI and high-throughput serum proteomics to investigate mechanisms of coronary endothelial dysfunction in treated HIV. Forty-five virally suppressed PWH and twenty-nine age- and sex-matched healthy controls underwent coronary MRI during isometric handgrip exercise to quantify coronary endothelial function, defined as the percentage change in coronary cross-sectional area (%CSA) from rest to stress. An increase in coronary CSA <2% indicated endothelial dysfunction. Parallel serum proteomic profiling was performed using the SomaScan 7K platform, and differential protein expression between groups was analyzed using linear modeling (LIMMA). Results: Coronary endothelial dysfunction was more prevalent in PWH with suppressed viral load compared to controls (67% vs 10%, p<0.001). Pathway analysis of differentially expressed proteins between participants with and without endothelial dysfunction highlighted significant dysregulation of glutathione dependent detoxification, oxidative metabolism and fatty acid β-oxidation pathways in individuals with endothelial dysfunction (adjusted p value <0.05). Conclusions: Endothelial dysfunction in PWH on ART is associated with metabolic and redox imbalance. These findings highlight glutathione and fatty acid oxidation related pathways as potential therapeutic targets for reducing cardiovascular risk in this patient population.
Open AccessMetabolic and Redox Pathway Dysregulation in HIV-Associated Coronary Endothelial Dysfunction
Background: People with HIV (PWH), even with sustained viral suppression on antiretroviral therapy (ART), remain at increased risk for cardiovascular disease. Coronary endothelial dysfunction, a sensitive marker of early vascular injury and a potential target for intervention is common in this population, but its biological basis remains unknown. Methods: We performed a cross-sectional study combining in vivo coronary MRI and high-throughput serum proteomics to investigate mechanisms of coronary endothelial dysfunction in treated HIV. Forty-five virally suppressed PWH and twenty-nine age- and sex-matched healthy controls underwent coronary MRI during isometric handgrip exercise to quantify coronary endothelial function, defined as the percentage change in coronary cross-sectional area (%CSA) from rest to stress. An increase in coronary CSA <2% indicated endothelial dysfunction. Parallel serum proteomic profiling was performed using the SomaScan 7K platform, and differential protein expression between groups was analyzed using linear modeling (LIMMA). Results: Coronary endothelial dysfunction was more prevalent in PWH with suppressed viral load compared to controls (67% vs 10%, p<0.001). Pathway analysis of differentially expressed proteins between participants with and without endothelial dysfunction highlighted significant dysregulation of glutathione dependent detoxification, oxidative metabolism and fatty acid β-oxidation pathways in individuals with endothelial dysfunction (adjusted p value <0.05). Conclusions: Endothelial dysfunction in PWH on ART is associated with metabolic and redox imbalance. These findings highlight glutathione and fatty acid oxidation related pathways as potential therapeutic targets for reducing cardiovascular risk in this patient population.
- Open Access
Ultra-Processed Food Consumption and Subclinical Cardiac Biomarkers: A Cross-Sectional Analysis of U.S. Adults in NHANES 2001–2004
Background/Objectives: Ultra-processed food consumption has been shown to be linked with clinical cardiovascular disease. This study aims to examine the associations of ultra-processed food consumption with biomarkers for subclinical-level myocardial damage [high-sensitivity cardiac troponin I and T (hs-cTnI and hs-cTnT)] and myocardial stretch (NT-proBNP) in U.S. adults. Methods: We used data from 6615 U.S. adults aged ≥20 years without prevalent cardiovascular disease from the National Health and Nutrition Examination Survey 2001–2004. We identified ultra-processed food by applying the Nova classification to dietary recall data, and we divided participants into quartiles based on their consumption, expressed as a proportion of total daily energy (%kcal) and gram intakes (%grams). We defined elevated cardiac biomarkers as hs-cTnI > 12 ng/L in men and >10 ng/L in women, hs-cTnT ≥ 14 ng/L for all participants, and NT-proBNP ≥ 125 pg/mL for age < 75 y and ≥450 pg/mL for age ≥ 75 y. We used multivariable logistic regression with adjustment for socio-demographic, total energy intake, behavioral, and clinical characteristics. Results: Higher ultra-processed food intake in %grams was associated with elevated NT-proBNP [odds ratio (OR) for quartile 4 vs. 1: 1.27, 95% CI: 1.00–1.61] when socio-demographic characteristics and total energy intake were adjusted for, but this was not the case with hs-cTnI or hs-cTnT. Further adjusting for clinical characteristics attenuated the association with NT-proBNP (OR: 1.26, 95% CI: 0.98, 1.61). There was no consistent association between ultra-processed food in %kcal and elevated NT-proBNP, hs-cTnT, or hs-cTnI. Conclusions: Ultra-processed food consumption is associated with subclinical myocardial stretch, a precursor to early heart failure. This supports the potential risks of subclinical cardiovascular disease associated with consuming ultra-processed food.
Open AccessUltra-Processed Food Consumption and Subclinical Cardiac Biomarkers: A Cross-Sectional Analysis of U.S. Adults in NHANES 2001–2004
Background/Objectives: Ultra-processed food consumption has been shown to be linked with clinical cardiovascular disease. This study aims to examine the associations of ultra-processed food consumption with biomarkers for subclinical-level myocardial damage [high-sensitivity cardiac troponin I and T (hs-cTnI and hs-cTnT)] and myocardial stretch (NT-proBNP) in U.S. adults. Methods: We used data from 6615 U.S. adults aged ≥20 years without prevalent cardiovascular disease from the National Health and Nutrition Examination Survey 2001–2004. We identified ultra-processed food by applying the Nova classification to dietary recall data, and we divided participants into quartiles based on their consumption, expressed as a proportion of total daily energy (%kcal) and gram intakes (%grams). We defined elevated cardiac biomarkers as hs-cTnI > 12 ng/L in men and >10 ng/L in women, hs-cTnT ≥ 14 ng/L for all participants, and NT-proBNP ≥ 125 pg/mL for age < 75 y and ≥450 pg/mL for age ≥ 75 y. We used multivariable logistic regression with adjustment for socio-demographic, total energy intake, behavioral, and clinical characteristics. Results: Higher ultra-processed food intake in %grams was associated with elevated NT-proBNP [odds ratio (OR) for quartile 4 vs. 1: 1.27, 95% CI: 1.00–1.61] when socio-demographic characteristics and total energy intake were adjusted for, but this was not the case with hs-cTnI or hs-cTnT. Further adjusting for clinical characteristics attenuated the association with NT-proBNP (OR: 1.26, 95% CI: 0.98, 1.61). There was no consistent association between ultra-processed food in %kcal and elevated NT-proBNP, hs-cTnT, or hs-cTnI. Conclusions: Ultra-processed food consumption is associated with subclinical myocardial stretch, a precursor to early heart failure. This supports the potential risks of subclinical cardiovascular disease associated with consuming ultra-processed food.
- 7 October 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (14) , 1037-1039
Two-Week Atrial Fibrillation Burden and Incident Heart Failure Among Older Individuals in the ARIC Study
- 7 October 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (14) , 1037-1039
Two-Week Atrial Fibrillation Burden and Incident Heart Failure Among Older Individuals in the ARIC Study
- Top Cited Papers
- 9 September 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (11) , e142-e144
Global and Regional Prediabetes Prevalence: Updates for 2024 and Projections for 2050
- 9 September 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (11) , e142-e144
Top Cited PapersGlobal and Regional Prediabetes Prevalence: Updates for 2024 and Projections for 2050
- Open Access
- 9 June 2025
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 23, 101029
Association of plant-based diets with subclinical cardiovascular disease in U.S. adults, 1999-2004
- 9 June 2025
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 23, 101029
Open AccessAssociation of plant-based diets with subclinical cardiovascular disease in U.S. adults, 1999-2004
- 22 April 2025
- Published by Elsevier in American Heart Journal
- Vol. 287, 79-85
Factors associated with NT-proBNP concentration in US children and adolescents: National Health and Nutrition Examination Survey 1999-2004
- 22 April 2025
- Published by Elsevier in American Heart Journal
- Vol. 287, 79-85
Factors associated with NT-proBNP concentration in US children and adolescents: National Health and Nutrition Examination Survey 1999-2004